Derek Sloan, M.D. joined Agenovir as the Director of Research in October 2015, bringing over 17 years of post-graduate research experience in the fields of virology, immunology, and cancer cell biology. Most recently, he served as Senior Scientist at Gilead Sciences, where he led a biology discovery team involved in the HIV Cure program. Prior to Gilead, he served in escalating scientific management roles at MedImmune and Immune Design, where he led and advanced herpes simplex vaccine programs. Before moving to industry, Dr. Sloan served on the faculty of the University of Washington School of Medicine. He earned his M.D. from the UC San Diego and his B.A. in Immunology and Microbiology from the UC Berkeley.